Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
about
The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.Diffusion Tensor Imaging in Movement Disorders: Review of Major Patterns and Correlation with Normal Brainstem/cerebellar White Matter.The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1.Clinical Application of Brain MRI in the Diagnostic Work-up of Parkinsonism.Magnetic resonance imaging in progressive supranuclear palsy.Selective frontal neurodegeneration of the inferior fronto-occipital fasciculus in progressive supranuclear palsy (PSP) demonstrated by diffusion tensor tractographyMovement disorders: role of imaging in diagnosis.Neurotoxic lesions at the ventral mesopontine junction change sleep time and muscle activity during sleep: an animal model of motor disorders in sleep.The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome.Patterns of gray matter atrophy in atypical parkinsonism syndromes: a VBM meta-analysisConventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism.Contribution of routine brain MRI to the differential diagnosis of parkinsonism: a 3-year prospective follow-up study.A molecular signature in blood identifies early Parkinson's disease.Specificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy.Voxel-based morphometry in autopsy proven PSP and CBDProposed neuroimaging criteria for the diagnosis of multiple system atrophy.Imaging synucleinopathies.Ancillary investigations to diagnose parkinsonism: a prospective clinical study.Clinical correlates of similar pathologies in parkinsonian syndromes.Subcortical structures in progressive supranuclear palsy: vertex-based analysis.A decision tree for differentiating multiple system atrophy from Parkinson's disease using 3-T MR imaging.Diagnosis of multiple system atrophy.Hummingbird sign in progressive supranuclear palsy.Susceptibility-weighted imaging improves the diagnostic accuracy of 3T brain MRI in the work-up of parkinsonism.Cerebellar lesions in multiple system atrophy: postmortem MR imaging-pathologic correlations.Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging.Significance of combined use of MRI and perfusion SPECT for evaluation of multiple system atrophy, cerebellar type.Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophyA magnetization transfer study of mild and advanced Parkinson’s disease
P2860
Q27011665-F0C452A2-5BC4-4DBC-85FC-E35C96499C2CQ30588544-77991D61-B88D-4627-96A6-71A1CA7C0760Q30669292-15A03494-BA6F-4085-AFB4-E4FCB3A94A2DQ30829363-D7FB2553-A5C7-4ED2-9FB5-C68A1264B712Q33708957-B7B76F2F-4BA4-4B68-A9E2-1337ED16EA04Q33779124-E2A5D971-DBD7-410A-BB99-224F842354B3Q33804380-30E03E2A-E95A-464D-A851-6FF1829AD43DQ34136898-F93EB194-16BB-4916-BF9E-6CF72F91B74BQ34816150-9B391EE9-E4B8-434B-9C2A-7D93D9F2D44BQ35693075-10478563-9E34-41C2-8E45-64950F9C6FA0Q35743561-FB64F53E-C618-4675-B76C-C655728B3CDCQ35829608-3D72297C-015E-4923-9F60-359759A643D5Q35985340-2073ABDB-1ACF-40CA-A0BC-95F6EAD30408Q36179021-96B65FC9-6D88-456B-B7FF-F2C405E46C1FQ36354065-CFBA430D-8B38-4BC8-ABE1-74226A930143Q37243463-DCF2ACC0-BD06-4996-AC5F-55874B80BBBCQ37420656-1EB4CAAE-8E93-4236-BE14-C903A6CD15F4Q38734660-5A52F625-D24E-48F9-89E5-954CEC366098Q39100999-67D8B078-6313-46F5-A975-651CDA84C177Q42482935-7A69DB9A-3781-42BF-9711-96D5ADEE906FQ44214592-8983BE51-8EE4-4104-AA92-908121D70D7FQ45227588-5204C3B0-5BF8-47AE-A27E-2C0E42689742Q47665262-EE13DE42-27F8-4C3B-810C-AE1F2230EB66Q48169553-D2EA6B0F-B6F8-449D-AB03-9209DB0E52A3Q48258693-747AA746-154F-4D12-A84D-FDB13EC2802FQ48560896-9D3E945F-0C13-4496-BDB3-7ACFECCE3A4FQ48694019-3DC5EFEE-D26F-4A07-9593-2DA8A199DD12Q52992034-AB22D99E-D030-4059-83D6-5EFD0C1B3220Q57384519-9996C405-370D-434B-91C0-DA9A987C84E3Q57750810-10715B37-6626-4D2F-9DAD-9E1E5DA5D2F0
P2860
Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
@en
Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
@nl
type
label
Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
@en
Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
@nl
prefLabel
Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
@en
Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
@nl
P2093
P1476
Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
@en
P2093
P2888
P304
P356
10.1007/S00702-002-0785-5
P577
2003-02-01T00:00:00Z